These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33603774)

  • 1. Genetically Modified Rabbits for Cardiovascular Research.
    Fan J; Wang Y; Chen YE
    Front Genet; 2021; 12():614379. PubMed ID: 33603774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically Engineered Hamster Models of Dyslipidemia and Atherosclerosis.
    Xian X; Wang Y; Liu G
    Methods Mol Biol; 2022; 2419():433-459. PubMed ID: 35237980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine.
    Fan J; Kitajima S; Watanabe T; Xu J; Zhang J; Liu E; Chen YE
    Pharmacol Ther; 2015 Feb; 146():104-19. PubMed ID: 25277507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7.
    Lu R; Yuan T; Wang Y; Zhang T; Yuan Y; Wu D; Zhou M; He Z; Lu Y; Chen Y; Fan J; Liang J; Cheng Y
    EBioMedicine; 2018 Oct; 36():29-38. PubMed ID: 30243490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-fed and transgenic rabbit models for the study of atherosclerosis.
    Fan J; Watanabe T
    J Atheroscler Thromb; 2000; 7(1):26-32. PubMed ID: 11425041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and Transcriptomic Analysis of Hypercholesterolemic Rabbits: Progress and Perspectives.
    Fan J; Chen Y; Yan H; Liu B; Wang Y; Zhang J; Chen YE; Liu E; Liang J
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30413026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Targeting in Rabbits: Single-Step Generation of Knock-out Rabbits by Microinjection of CRISPR/Cas9 Plasmids.
    Kawano Y; Honda A
    Methods Mol Biol; 2017; 1630():109-120. PubMed ID: 28643254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles and Applications of Rabbit Models for Atherosclerosis Research.
    Fan J; Chen Y; Yan H; Niimi M; Wang Y; Liang J
    J Atheroscler Thromb; 2018 Mar; 25(3):213-220. PubMed ID: 29046488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic rabbit models for cardiac disease research.
    Hornyik T; Rieder M; Castiglione A; Major P; Baczko I; Brunner M; Koren G; Odening KE
    Br J Pharmacol; 2022 Mar; 179(5):938-957. PubMed ID: 33822374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins.
    Bosze Z; Hiripi L; Carnwath JW; Niemann H
    Transgenic Res; 2003 Oct; 12(5):541-53. PubMed ID: 14601653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Assisted Genome Editing in Murine Embryonic Stem Cells.
    Gruzdev A; Scott GJ; Hagler TB; Ray MK
    Methods Mol Biol; 2019; 1960():1-21. PubMed ID: 30798517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis.
    Fan J; Unoki H; Kojima N; Sun H; Shimoyamada H; Deng H; Okazaki M; Shikama H; Yamada N; Watanabe T
    J Biol Chem; 2001 Oct; 276(43):40071-9. PubMed ID: 11477088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.
    Motta BM; Pramstaller PP; Hicks AA; Rossini A
    Stem Cells Int; 2017; 2017():8960236. PubMed ID: 29434642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Editing in Mouse Embryos with CRISPR/Cas9.
    Scott GJ; Gruzdev A
    Methods Mol Biol; 2019; 1960():23-40. PubMed ID: 30798518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome engineering technologies in rabbits.
    Song J; Zhang J; Xu J; Garcia-Barrio M; Chen YE; Yang D
    J Biomed Res; 2020 Jun; 35(2):135-147. PubMed ID: 32934190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Genetically Modified Mice Using the CRISPR-Cas9 Genome-Editing System.
    Henao-Mejia J; Williams A; Rongvaux A; Stein J; Hughes C; Flavell RA
    Cold Spring Harb Protoc; 2016 Feb; 2016(2):pdb.prot090704. PubMed ID: 26832688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered livestock for agriculture: a generation after the first transgenic animal research conference.
    Murray JD; Maga EA
    Transgenic Res; 2016 Jun; 25(3):321-7. PubMed ID: 26820413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reverse cholesterol transport and use of transgenic mice and rabbits to reveal candidate genes for protection against atherosclerosis].
    Fruchart JC; Duriez P
    Bull Acad Natl Med; 1998; 182(2):233-47; discussion 247-9. PubMed ID: 9648340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoE knockout rabbits: A novel model for the study of human hyperlipidemia.
    Niimi M; Yang D; Kitajima S; Ning B; Wang C; Li S; Liu E; Zhang J; Eugene Chen Y; Fan J
    Atherosclerosis; 2016 Feb; 245():187-93. PubMed ID: 26724529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.